Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -22.63% is 75% above its 5-year average of -89.51%, near the high end of its 5-year range (-897.82%–84.95%).
93.26% above its 12-month average of -335.70%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -897.82%.
OPERATING MARGIN
-22.63%
OPERATING MARGIN AVG TTM
-335.70%
OPERATING MARGIN AVG 3Y
-197.73%
OPERATING MARGIN AVG 5Y
-89.51%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+93.26%
CURRENT VS 3Y AVG
+88.56%
CURRENT VS 5Y AVG
+74.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-251.88%
vs the sector median at left
BioNTech SE
Market Cap
$24.29B
Operating Margin
-22.63%
TTM Avg
-335.70%
3Y Avg
-197.73%
5Y Avg
-89.51%
Market Cap
$24.68B
Operating Margin
31.57%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$25.68B
Operating Margin
20.64%
TTM Avg
20.32%
3Y Avg
22.80%
5Y Avg
22.92%
Market Cap
$26.57B
Operating Margin
11.27%
TTM Avg
9.61%
3Y Avg
9.32%
5Y Avg
13.00%
Market Cap
$26.88B
Operating Margin
28.69%
TTM Avg
28.45%
3Y Avg
28.53%
5Y Avg
27.71%
Market Cap
$27.29B
Operating Margin
14.14%
TTM Avg
14.08%
3Y Avg
14.06%
5Y Avg
16.54%
Market Cap
$21.24B
Operating Margin
44.49%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.29B | -22.63% | -335.70% | -197.73% | -89.51% |
| Incyte Corporation (INCY)vs › | $24.68B | 31.57% | 14.26% | 15.92% | 12.23% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.68B | 20.64% | 20.32% | 22.80% | 22.92% |
| Labcorp Holdings Inc. (LH)vs › | $26.57B | 11.27% | 9.61% | 9.32% | 13.00% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.88B | 28.69% | 28.45% | 28.53% | 27.71% |
| Medline Inc. (MDLN)vs › | $27.15B | 6.07% | 8.25% | 6.70% | 6.70% |
| Quest Diagnostics Incorporated (DGX)vs › | $27.29B | 14.14% | 14.08% | 14.06% | 16.54% |
| United Therapeutics Corporation (UTHR)vs › | $21.24B | 44.49% | 47.77% | 49.26% | 45.01% |
| STERIS plc (STE)vs › | $20.49B | 18.91% | 17.21% | 17.04% | 16.18% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.94B | 12.70% | 13.37% | 13.23% | 14.11% |
Gross Margin
71.0%
Operating Margin
-22.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -897.82% |
| 2026-03-31 | -559.78% |
| 2025-12-31 | -25.66% |
| 2025-09-30 | -3.09% |
| 2025-06-30 | -192.14% |
| 2025-03-31 | -292.18% |
| 2024-12-31 | 12.49% |
| 2024-09-30 | 0.84% |
| 2024-06-30 | -750.74% |
| 2024-03-31 | -270.36% |
| 2023-12-31 | 35.58% |
| 2023-09-30 | 8.16% |
| 2023-06-30 | -335.90% |
| 2023-03-31 | 51.25% |
| 2022-12-31 | 76.97% |
| 2022-09-30 | 68.98% |
| 2022-06-30 | 69.13% |
| 2022-03-31 | 74.56% |
| 2021-12-31 | 84.95% |
| 2021-09-30 | 77.60% |
| 2021-06-30 | 79.09% |
| 2021-03-31 | 81.15% |
| 2020-12-31 | 70.69% |
| 2020-09-30 | -276.15% |
| 2020-06-30 | -194.00% |
| 2020-03-31 | -214.08% |
| 2019-12-31 | -189.16% |
| 2019-09-30 | -128.65% |
| 2019-06-30 | -185.64% |
| 2019-03-31 | -167.60% |
| 2018-12-31 | -3.76% |
| 2018-09-30 | -106.04% |
| 2018-06-30 | -68.74% |
| 2018-03-31 | -68.74% |
